Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Helen Dakin, S Wordsworth , Chris Rogers, G abangma, J Raferty , Simon P Harding, Andrew J Lotery, S M Downes, Usha Chakravarthy, Barnaby Reeves

Research output: Contribution to journalArticle (Academic Journal)peer-review

49 Citations (Scopus)

Search results

  • Finished

    ConDuCT-II

    Blazeby, J.

    1/04/1431/03/19

    Project: Research